In OI, pathogenic COL1A1 and COL1A2 variants contribute to increased bone fragility in part through reductions in bone matrix strength stemming from alterations in collagen resulting in an increased mineral-matrix ratio.13 The gene discussed is COL1A1; the disease is osteogenesis imperfecta.